Search Results

10 Results for "zymequest".

Sort By

Business

ZymeQuest Licenses Proprietary Enzyme Technology to Publicly Traded Life Sciences Company

January 2, 2008
·
1 min read
Business

ZymeQuest Signs Process Development And Manufacturing Agreement With Cambrex Corporation

October 19, 2005
·
1 min read
Business

Inozyme Pharma Appoints Kurt Gunter, M.D., as Chief Medical Officer

Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of abnormal mineralization, today announced the appointment of Kurt Gunter, M.D., as chief medical officer.

June 7, 2022
·
6 min read
Business

BioSpace Movers & Shakers: Third Harmonic, Inozyme, Athira, Aurion and More

Third Harmonic Bio, Akili Interactive, the Rare Disease Company Coalition, Inozyme, Athira, Cytovia and many more made major leadership decisions this week.

June 9, 2022
·
7 min read
·
Alex Keown
Business

OncXerna Therapeutics Appoints C. Evan Ballantyne as Chief Financial Officer

OncXerna Therapeutics, Inc., a precision medicine company using an innovative RNA-expression based biomarker platform to predict patient responses to its targeted oncology therapies, announced the appointment of Evan Ballantyne as Chief Financial Officer.

August 17, 2021
·
3 min read
Business

BioSpace Movers & Shakers, Aug. 20

Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.

August 19, 2021
·
8 min read
·
Alex Keown
Business

5-Member GO Therapeutics Inks $195 Million Deal with Roche

GO Therapeutics, headquartered in Cambridge, Mass., signed a licensing deal with Swiss-based Roche to develop antibodies for cancer.

October 2, 2018
·
3 min read
·
Mark Terry
Business

Jeffrey H. Burbank Joins CryoLife Board Of Directors

October 2, 2017
·
2 min read
Business

Accera, Inc. Appoints C. Evan Ballantyne As Chief Financial Officer

August 2, 2016
·
3 min read
Business

Adeona Pharmaceuticals Appoints C. Evan Ballantyne as Chief Financial Officer

February 7, 2012
·
3 min read